References
Lum LG. The Kinetics of immune reconstitution after human marrow transplantation.Blood. 1987;69:369–380.
Roberts MM, To LB, Gillis D, et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation.Bone Marrow Transplant. 1993;12:469–475.
Kook H, Goldman F, Padley D, et al. Reconstruction of the immune system after unrelated or partially matched T-cell depleted bone marrow transplantation in children: Immunophenotypic analysis and factors affecting the speed of recovery.Blood. 1996;88:1089–1097.
Kook H, Goldman F, Giller R, et al. Reconstruction of the immune system after unrelated or partially matched T-cell depleted bone marrow transplantation in children: Functional analyses of lymphocytes and correlation with immunophenotypic recovery following transplant.Clin Diagn Lab Immunol. 1997;4:96–103.
Clark RA, Johnson FL, Klebanoff SJ, Thomas ED. Defective neutrophil chemotaxis in bone marrow transplant patients.J Clin Invest. 1976;58:22–31.
Foot ABM, Potter MN, Donaldson C, et al. Immune reconstitution after BMT in children.Bone Marrow Transplantat. 1993;11:7–13.
Fujimaki K, Maruta A, Yoshida M, et al. Immune reconstitution assessed during five years after allogeneic bone marrow transplantation.Bone Marrow Transplantat. 2001;27:1275–1281.
Lenarsky C. Mechanisms in immune recovery after bone marrow transplantation.Am J Pediatr Hematol Oncol. 1993;15: 49–55.
Storek J, Saxon A. Reconstitution of B cell immunity following bone marrow transplantation.Bone Marrow Transplantat. 1992;9:395–408.
Sullivan KM, Storek J, Kopecky KJ, et al. A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs-host disease after marrow transplantation: Clinical outcome and effect on subsequent immune recovery.Biol Blood Marrow Transplantat. 1996;2:44–53.
Storek J, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A. B-cell reconstitution after human bone marrow transplantation: Recapitulation of ontogeny?Bone Marrow Transplantat. 1993;12:387–398.
Llungman P. Immune reconstitution and viral infections after stem cell transplantation.Bone Marrow Transplantat. 1998;21: s72-s74.
Guillaume T, Rubinstein DB, Symann M. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation.Blood. 1998;92:1471–1490.
Lamb Jr LS, Gee AP, Henslee-Downey JP, et al. Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell depleted bone marrow transplantation from partially mismatched related donors.Bone Marrow Transplantat. 1998;21:461–471.
Moretta A, Maccario R, Fagioli F, et al. Analysis of immune reconstitution in children undergoing cord blood transplantation.Exp Hematol. 2001;29:371–379.
Klein AK, Patel DD, Gooding ME, et al. T-cell recovery in adults and children following umbilical cord blood transplantation.Biol Blood Marrow Transplantat. 2001;7:454–466.
Keever CA, Small TN, Flomenberg N, et al. Immune reconstitution following bone marrow transplantation: Comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts.Blood. 1989;73:1340–1350.
Locatelli F, Maccario R, Comoli P, et al. Hematopoietic and immune recovery after transplantation of cord blood progenitor cells in children.Bone Marrow Transplantat. 1996;18:1095–1101.
Hochberg EP, Chillemi AC, Wu CJ, et al. Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults.Blood. 2001;98:1116–1121.
Small TN, Keever CA, Weiner-Fedus S, Heller G, O’Reilly RJ, Flomenberg N. B-dell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: A recapitulation of normal B-cell ontogeny.Blood. 1990;76: 1647–1656.
Rozans MK, Smith BR, Burakoff SJ, Miller RA. Long-lasting deficit of functional T cell precursors in human bone marrow transplant recipients revealed by limiting dilution methods.J Immunol. 1986;136:4040–4048.
Storek J, Wells D, Dawson MJ, Storer B, Maloney DG. Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation.Blood. 2001;98:489–491.
Rowe JM, Nilsson BI, Simonsson B. Treatment of minimal residual disease in myeloid leukemiathe immunotherapeutic options with emphasis on Linomide.Leuk Lymphoma. 1993;11: 321–329.
Editorial. Discontinuing pneumocystis carinii prophylaxis.N Engl J Med. 2001;344:222–223.
Aotuska N, Asai T, Oh H, Yoshida S, Itoh K, Sato R. Lymphocyte subset reconstitution following human allogenic bone marrow transplantation: differences between engrafted patients and graft failure patients.Bone Marrow Transplantat. 1991;8: 345–349.
Shenoy S, Mohanakumar T, Todd G, et al. Immune reconstitution following allogeneic peripheral blood stem cell transplants.Bone Marrow Transplantat. 1999;23:335–346.
Champlin RE. T-cell depletion for bone marrow transplation: effects on graft rejection, graft-versus-host disease, graft-versusleukemia, and survival.Cancer Treat Res. 1990;50:99–111.
Author information
Authors and Affiliations
About this article
Cite this article
Trigg, M.E. Post-transplant immune recovery and the implication for infection risk. Int J Hematol 76 (Suppl 1), 199–205 (2002). https://doi.org/10.1007/BF03165245
Issue Date:
DOI: https://doi.org/10.1007/BF03165245